Novavax Inc (NASDAQ:NVAX)

Data as of Apr 17
 -0.02 / -0.49%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Novavax, Inc. is a clinical-stage biopharmaceutical company, which engages in development of novel recombinant vaccines to address a broad range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles and recombinant nanoparticle vaccines. Its product pipeline targets a variety of infectious diseases and currently has completed clinical trials that target pandemic influenza (H5N1), seasonal influenza and Respiratory Syncytial Virus. The company is committed to using its technology platform to create geographic-specific vaccine solutions and is therefore involved in several international partnerships, including collaborations with Cadila Pharmaceuticals Ltd. of India, LG Life Sciences Ltd. of Korea and PATH. Novavax was founded in 1987 and is headquartered in Rockville, MD.

Contact Information

Novavax, Inc.
9920 Belward Campus Drive
Rockville Maryland 20850
P:(240) 268-2000
Investor Relations:



Individual stakeholders8.01%
Mutual fund holders32.84%
Other institutional21.70%

Top Executives

Stanley C. ErckPresident, Chief Executive Officer & Director
Barclay A. PhillipsChief Financial Officer, Treasurer & SVP
Gregory M. GlennChief Medical Officer & Senior Vice President
Louis F. FriesChief Medical Officer & Vice President
D. Nigel ThomasVice President-Clinical Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.